Koya, T.; Yoshida, K.; Togi, M.; Niida, Y.; Togi, S.; Ura, H.; Mizuta, S.; Kato, T., Jr.; Yamada, S.; Shibata, T.;
et al. Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells. Cancers 2023, 15, 3627.
https://doi.org/10.3390/cancers15143627
AMA Style
Koya T, Yoshida K, Togi M, Niida Y, Togi S, Ura H, Mizuta S, Kato T Jr., Yamada S, Shibata T,
et al. Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells. Cancers. 2023; 15(14):3627.
https://doi.org/10.3390/cancers15143627
Chicago/Turabian Style
Koya, Terutsugu, Kenichi Yoshida, Misa Togi, Yo Niida, Sumihito Togi, Hiroki Ura, Shuichi Mizuta, Tomohisa Kato, Jr., Sohsuke Yamada, Takeo Shibata,
and et al. 2023. "Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells" Cancers 15, no. 14: 3627.
https://doi.org/10.3390/cancers15143627
APA Style
Koya, T., Yoshida, K., Togi, M., Niida, Y., Togi, S., Ura, H., Mizuta, S., Kato, T., Jr., Yamada, S., Shibata, T., Liu, Y.-C., Yuan, S.-S., Wu, D.-C., Kobayashi, H., Utsugisawa, T., Kanno, H., & Shimodaira, S.
(2023). Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells. Cancers, 15(14), 3627.
https://doi.org/10.3390/cancers15143627